Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Enzyme Inhib Med Chem ; 25(3): 301-5, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19874209

RESUMEN

The synthesis of new N-homopiperazinyl-based ligands is reported. Various structural modifications along with the corresponding biological activities on 5-HT(1A)/5-HT(7) receptors give further insights into this class of serotoninergic ligands. Among the tested central heterocyles, the 7-azaindole gave the best results on the above-mentioned receptors.


Asunto(s)
Piperazinas/química , Agonistas de Receptores de Serotonina/química , Diseño de Fármacos , Humanos , Indoles , Ligandos , Piperazina , Piperazinas/síntesis química , Piperazinas/farmacología , Unión Proteica , Ensayo de Unión Radioligante , Receptor de Serotonina 5-HT1A , Receptores de Serotonina , Agonistas de Receptores de Serotonina/síntesis química , Relación Estructura-Actividad
2.
Eur J Med Chem ; 83: 617-29, 2014 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-24998602

RESUMEN

New series of 2,3,4,5-tetrahydro[1,4]diazepino[1,2-a]indol-1-ones and 3,4,5,10-tetrahydro-2H-diazepino[3,4-b]indol-1-ones have been synthesized through an iodolactonisation/lactone-to-lactam rearrangement sequence. These compounds were evaluated as potential protein kinase inhibitors (CDK1, CDK5 and GSK-3). 11-Iodo-2,3,4,5-tetrahydro[1,4]diazepino[1,2-a]indol-1-one derivatives exhibited sub-micromolar inhibitory activity against cyclin-dependent kinases. Docking studies were realized to determine the binding mode of the inhibitors into the ATP binding domain of the CDK5 catalytic site. Our result highlighted two weak Van-der-Waals bonding interactions established between the iodine atom and both phenyl group of Phe 80 and ammonium end of Lys 33.


Asunto(s)
Quinasas Ciclina-Dependientes/antagonistas & inhibidores , Indoles/síntesis química , Indoles/farmacología , Inhibidores de Proteínas Quinasas/síntesis química , Inhibidores de Proteínas Quinasas/farmacología , Animales , Dominio Catalítico , Técnicas de Química Sintética , Quinasas Ciclina-Dependientes/química , Quinasas Ciclina-Dependientes/metabolismo , Humanos , Indoles/química , Indoles/metabolismo , Simulación del Acoplamiento Molecular , Inhibidores de Proteínas Quinasas/química , Inhibidores de Proteínas Quinasas/metabolismo , Relación Estructura-Actividad
3.
J Med Chem ; 53(5): 2155-70, 2010 Mar 11.
Artículo en Inglés | MEDLINE | ID: mdl-20148564

RESUMEN

Single agents against multiple drug targets are of increasing interest. Hormone-dependent breast cancer (HDBC) may be more effectively treated by dual inhibition of aromatase and steroid sulfatase (STS). The aromatase inhibitory pharmacophore was thus introduced into a known biphenyl STS inhibitor to give a series of novel dual aromatase-sulfatase inhibitors (DASIs). Several compounds are good aromatase or STS inhibitors and DASI 20 (IC(50): aromatase, 2.0 nM; STS, 35 nM) and its chlorinated congener 23 (IC(50): aromatase, 0.5 nM; STS, 5.5 nM) are examples that show exceptional dual potency in JEG-3 cells. Both biphenyls share a para-sulfamate-containing ring B and a ring A, which contains a triazol-1-ylmethyl meta to the biphenyl bridge and para to a nitrile. At 1 mg/kg po, 20 and 23 reduced plasma estradiol levels strongly and inhibited liver STS activity potently in vivo. 23 is nonestrogenic and potently inhibits carbonic anhydrase II (IC(50) 86 nM). A complex was crystallized and its structure was solved by X-ray crystallography. This class of DASI should encourage further development toward multitargeted therapeutic intervention in HDBC.


Asunto(s)
Inhibidores de la Aromatasa/química , Inhibidores de la Aromatasa/farmacología , Compuestos de Bifenilo/química , Compuestos de Bifenilo/farmacología , Esteril-Sulfatasa/antagonistas & inhibidores , Triazoles/química , Triazoles/farmacología , Animales , Inhibidores de la Aromatasa/síntesis química , Compuestos de Bifenilo/síntesis química , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Cristalografía por Rayos X , Femenino , Humanos , Concentración 50 Inhibidora , Espectroscopía de Resonancia Magnética , Ratas , Ratas Wistar , Espectrometría de Masa por Ionización de Electrospray , Esteril-Sulfatasa/metabolismo , Relación Estructura-Actividad , Triazoles/síntesis química
4.
J Med Chem ; 52(19): 5916-25, 2009 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-19743863

RESUMEN

Several small weight indole derivatives (D-64131, D-24851, BPR0L075, BLF 61-3, and ATI derivatives) are potent tubulin polymerization inhibitors and show nanomolar antiproliferative activity. Among them, indolobenzazepin-7-ones were recently disclosed as potent antimitotic agents. In an effort to improve this structure, we prepared new derivatives in order to evaluate their antiproliferative activity. 5,6,7,9-Tetrahydro-8H-indolo[2,3-e][3]benzazocin-8-one (1m) was found to be the most potent derivative inhibiting the cell growth of several cancer cell lines in the lower nanomolar range.


Asunto(s)
Benzazepinas/farmacología , Moduladores de Tubulina/síntesis química , Antineoplásicos/síntesis química , Benzazepinas/síntesis química , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Indoles/síntesis química , Indoles/farmacología , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA